227 related articles for article (PubMed ID: 26493319)
1. Risk environments facing potential users of a supervised injection site in Ottawa, Canada.
Shaw A; Lazarus L; Pantalone T; LeBlanc S; Lin D; Stanley D; Chepesiuk C; Patel S; Tyndall M;
Harm Reduct J; 2015 Oct; 12():49. PubMed ID: 26493319
[TBL] [Abstract][Full Text] [Related]
2. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
Kennedy MC; Hayashi K; Milloy MJ; Wood E; Kerr T
PLoS Med; 2019 Nov; 16(11):e1002964. PubMed ID: 31770391
[TBL] [Abstract][Full Text] [Related]
3. Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City.
Mitra S; Rachlis B; Scheim A; Bardwell G; Rourke SB; Kerr T
Harm Reduct J; 2017 Jul; 14(1):46. PubMed ID: 28709471
[TBL] [Abstract][Full Text] [Related]
4. Willingness to use drug checking within future supervised injection services among people who inject drugs in a mid-sized Canadian city.
Kennedy MC; Scheim A; Rachlis B; Mitra S; Bardwell G; Rourke S; Kerr T
Drug Alcohol Depend; 2018 Apr; 185():248-252. PubMed ID: 29475198
[TBL] [Abstract][Full Text] [Related]
5. Navigating environmental constraints to injection preparation: the use of saliva and other alternatives to sterile water among unstably housed PWID in London.
Harris M; Scott J; Hope V; Wright T; McGowan C; Ciccarone D
Harm Reduct J; 2020 Apr; 17(1):24. PubMed ID: 32276626
[TBL] [Abstract][Full Text] [Related]
6. A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study.
Werb D; Garfein R; Kerr T; Davidson P; Roux P; Jauffret-Roustide M; Auriacombe M; Small W; Strathdee SA
Harm Reduct J; 2016 Sep; 13(1):25. PubMed ID: 27629248
[TBL] [Abstract][Full Text] [Related]
7. Establishing a community-based participatory research partnership among people who use drugs in Ottawa: the PROUD cohort study.
Lazarus L; Shaw A; LeBlanc S; Martin A; Marshall Z; Weersink K; Lin D; Mandryk K; Tyndall MW;
Harm Reduct J; 2014 Oct; 11(1):26. PubMed ID: 25307356
[TBL] [Abstract][Full Text] [Related]
8. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
[TBL] [Abstract][Full Text] [Related]
9. Potential use of supervised injection services among people who inject drugs in a remote and mid-size Canadian setting.
Mitra S; Rachlis B; Krysowaty B; Marshall Z; Olsen C; Rourke S; Kerr T
BMC Public Health; 2019 Mar; 19(1):284. PubMed ID: 30849946
[TBL] [Abstract][Full Text] [Related]
10. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
[TBL] [Abstract][Full Text] [Related]
11. Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
Scheibe A; Young K; Moses L; Basson RL; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Manamela J; Puren AJ; Rebe K; Hausler H
Harm Reduct J; 2019 Apr; 16(1):28. PubMed ID: 30975139
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs.
Trayner KMA; McAuley A; Palmateer NE; Goldberg DJ; Shepherd SJ; Gunson RN; Tweed EJ; Priyadarshi S; Milosevic C; Hutchinson SJ
Int J Drug Policy; 2020 Mar; 77():102663. PubMed ID: 31981949
[TBL] [Abstract][Full Text] [Related]
13. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
14. HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden.
Tarján A; Dudás M; Wiessing L; Horváth G; Rusvai E; Tresó B; Csohán Á
Int J Drug Policy; 2017 Mar; 41():1-7. PubMed ID: 27984762
[TBL] [Abstract][Full Text] [Related]
15. Understanding the public health consequences of suspending a rural syringe services program: a qualitative study of the experiences of people who inject drugs.
Allen ST; Grieb SM; O'Rourke A; Yoder R; Planchet E; White RH; Sherman SG
Harm Reduct J; 2019 May; 16(1):33. PubMed ID: 31109339
[TBL] [Abstract][Full Text] [Related]
16. Supervised injection services: what has been demonstrated? A systematic literature review.
Potier C; Laprévote V; Dubois-Arber F; Cottencin O; Rolland B
Drug Alcohol Depend; 2014 Dec; 145():48-68. PubMed ID: 25456324
[TBL] [Abstract][Full Text] [Related]
17. Access to harm reduction programs among persons who inject drugs: findings from a respondent-driven sampling survey in Tehran, Iran.
Rahnama R; Mohraz M; Mirzazadeh A; Rutherford G; McFarland W; Akbari G; Malekinejad M
Int J Drug Policy; 2014 Jul; 25(4):717-23. PubMed ID: 24974367
[TBL] [Abstract][Full Text] [Related]
18. Willingness to utilize supervised injection facilities among people who inject drugs in Iran: Findings from 2020 national HIV bio-behavioral surveillance survey.
Khezri M; Karamouzian M; Sharifi H; Ghalekhani N; Tavakoli F; Mehmandoost S; Mehrabi F; Pedarzadeh M; Nejat M; Noroozi A; Baral S; Shokoohi M
Int J Drug Policy; 2021 Nov; 97():103355. PubMed ID: 34242959
[TBL] [Abstract][Full Text] [Related]
19. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of supervised injection facilities among persons who inject drugs in upstate New York.
Duncan E; Shufelt S; Barranco M; Udo T
Harm Reduct J; 2022 Jul; 19(1):87. PubMed ID: 35907854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
